Holocene Advisors, LP Revolution Medicines, Inc. Transaction History
Holocene Advisors, LP
- $31.7 Billion
- Q1 2025
A detailed history of Holocene Advisors, LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 3,691,744 shares of RVMD stock, worth $150 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
3,691,744
Previous 2,996,710
23.19%
Holding current value
$150 Million
Previous $131 Million
0.41%
% of portfolio
0.41%
Previous 0.45%
Shares
9 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$674 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$549 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$544 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$478 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$414 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.56B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...